Catalyst Wire Dossier Catalyst Wire Dossier

Autologous hapten-modified vaccine

· AVAX Technologies
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous hapten-modified vaccine, covering 2015-12-03 to 2015-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma [Phase 1, Phase 2]

See pricing